Literature DB >> 9717864

Negative, positive, and disorganized symptom dimensions in schizophrenia, major depression, and bipolar disorder.

R Toomey1, S V Faraone, J C Simpson, M T Tsuang.   

Abstract

We compared the factor structure of positive and negative symptoms in schizophrenia (N = 214), major depression (N = 97), and bipolar disorder (N = 58) to determine whether schizophrenia factors would generalize to mood disorders. A study of schizophrenia and mood disorders identified patients whose symptoms were evaluated with the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms. We conducted principal component analyses with orthogonal rotation on the global ratings. The factor structure replicated earlier findings of three factors (negative, positive, and disorganization) in groups with schizophrenia, combined mood disorders, and psychotic symptoms, regardless of diagnosis. An additional negative symptom factor was found in the major depression group. The bipolar group did not have a disorganization factor. Similar symptom factors in schizophrenia and mood disorders suggest a continuity in the major affective and psychotic disorders that appears to reflect the underlying dimension of a psychotic process.

Entities:  

Mesh:

Year:  1998        PMID: 9717864     DOI: 10.1097/00005053-199808000-00004

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  13 in total

Review 1.  Categorical vs dimensional classifications of psychotic disorders.

Authors:  Melissa Potuzak; Caitlin Ravichandran; Kathryn E Lewandowski; Dost Ongür; Bruce M Cohen
Journal:  Compr Psychiatry       Date:  2012-06-07       Impact factor: 3.735

2.  Neural markers of emotional face perception across psychotic disorders and general population.

Authors:  Amri Sabharwal; Roman Kotov; Akos Szekely; Hoi-Chung Leung; Deanna M Barch; Aprajita Mohanty
Journal:  J Abnorm Psychol       Date:  2017-05-29

3.  Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses.

Authors:  Kathryn E Lewandowski; Bruce M Cohen; Matcheri S Keshavan; Dost Ongür
Journal:  Schizophr Res       Date:  2011-10-12       Impact factor: 4.939

4.  Perceived emotional intelligence is impaired and associated with poor community functioning in schizophrenia and bipolar disorder.

Authors:  Naomi T Tabak; Michael F Green; Jonathan K Wynn; Greg H Proudfit; Lori Altshuler; William P Horan
Journal:  Schizophr Res       Date:  2015-01-09       Impact factor: 4.939

5.  Bipolar disorder risk gene FOXO6 modulates negative symptoms in schizophrenia: a neuroimaging genetics study.

Authors:  Joseph J Shenker; Sarojini M Sengupta; Ridha Joober; Ashok Malla; M Mallar Chakravarty; Martin Lepage
Journal:  J Psychiatry Neurosci       Date:  2017-05       Impact factor: 6.186

6.  Hierarchical Symptom Components in Early Psychosis.

Authors:  Julia M Longenecker; Gretchen L Haas; Dean F Salisbury
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

7.  Nonverbal delayed recognition in the relatives of schizophrenia patients with or without schizophrenia spectrum.

Authors:  Olalla Robles; Teresa Blaxton; Helene Adami; Celso Arango; Gunvant Thaker; James Gold
Journal:  Biol Psychiatry       Date:  2007-10-03       Impact factor: 13.382

8.  Measuring pathology using the PANSS across diagnoses: Inconsistency of the positive symptom domain across schizophrenia, schizoaffective, and bipolar disorder.

Authors:  Ariana E Anderson; Maxwell Mansolf; Steven P Reise; Adam Savitz; Giacomo Salvadore; Qingqin Li; Robert M Bilder
Journal:  Psychiatry Res       Date:  2017-08-16       Impact factor: 3.222

9.  Associations of independent living and labor force participation with impairment indicators in schizophrenia and bipolar disorder at 20-year follow-up.

Authors:  M Strassnig; R Kotov; L Fochtmann; M Kalin; E J Bromet; P D Harvey
Journal:  Schizophr Res       Date:  2018-02-19       Impact factor: 4.939

10.  Conceptualization of the liability for schizophrenia: clinical implications.

Authors:  M T Tsuang; W S Stone; S V Faraone
Journal:  Dialogues Clin Neurosci       Date:  1999-12       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.